FDA Acting Chief Counsel To Be Masoudi

Dan Troy will leave agency Nov. 24 after three years which included major Waxman/Hatch reforms and reconsideration of First Amendment issues. Newly appointed deputy chief counsel Masoudi will succeed Troy until a permanent chief counsel is selected by HHS’ Azar.